JPS5759813A - Alpha-glucosidase inhibitor - Google Patents

Alpha-glucosidase inhibitor

Info

Publication number
JPS5759813A
JPS5759813A JP13650080A JP13650080A JPS5759813A JP S5759813 A JPS5759813 A JP S5759813A JP 13650080 A JP13650080 A JP 13650080A JP 13650080 A JP13650080 A JP 13650080A JP S5759813 A JPS5759813 A JP S5759813A
Authority
JP
Japan
Prior art keywords
valienamine
glucosidase inhibitor
diseases
caused
inhibitor
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP13650080A
Other languages
Japanese (ja)
Inventor
Yukihiko Kameda
Satoshi Horii
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Takeda Pharmaceutical Co Ltd
Original Assignee
Takeda Chemical Industries Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Takeda Chemical Industries Ltd filed Critical Takeda Chemical Industries Ltd
Priority to JP13650080A priority Critical patent/JPS5759813A/en
Publication of JPS5759813A publication Critical patent/JPS5759813A/en
Pending legal-status Critical Current

Links

Landscapes

  • Saccharide Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

PURPOSE: The titled inhibitor comprising valienamine.
CONSTITUTION: An α-glucosidase inhibitor having inhibiting action on the increase in blood sugar, effective against hypergly cemia sympton and various kinds of diseases (e.g., obesity, adiposis, arterial sclerosis, diabetes, prediabetes, diseases caused by saccharometabolis resulting from microorganisms in the oral cavity) caused by hyperglycoplasmia, comprising valienamine. Valienamine as the active ingredient is obtained by making Pseudomonas denitrificans act on validamycin A or B or validoxylamine A. Valienamine is colorless crystal or powder, having almost no toxicity, being used alone or as a mixture with a nontoxic carrier, pharmaceutically manufactured into an ampul, capsule, granule, tablet, pill, syrup, suppository, etc. for use.
COPYRIGHT: (C)1982,JPO&Japio
JP13650080A 1980-09-29 1980-09-29 Alpha-glucosidase inhibitor Pending JPS5759813A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP13650080A JPS5759813A (en) 1980-09-29 1980-09-29 Alpha-glucosidase inhibitor

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP13650080A JPS5759813A (en) 1980-09-29 1980-09-29 Alpha-glucosidase inhibitor

Publications (1)

Publication Number Publication Date
JPS5759813A true JPS5759813A (en) 1982-04-10

Family

ID=15176611

Family Applications (1)

Application Number Title Priority Date Filing Date
JP13650080A Pending JPS5759813A (en) 1980-09-29 1980-09-29 Alpha-glucosidase inhibitor

Country Status (1)

Country Link
JP (1) JPS5759813A (en)

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPWO2004101493A1 (en) * 2003-05-19 2006-07-13 生化学工業株式会社 Acid addition salts of carbasugar amine derivatives
WO2007037423A1 (en) * 2005-09-29 2007-04-05 Kureha Corporation Antidiabetic agent
CN103688929A (en) * 2013-12-31 2014-04-02 福建省亚热带植物研究所 Validamycin nanocapsule, preparation method and application thereof

Cited By (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPWO2004101493A1 (en) * 2003-05-19 2006-07-13 生化学工業株式会社 Acid addition salts of carbasugar amine derivatives
JP4602249B2 (en) * 2003-05-19 2010-12-22 生化学工業株式会社 Acid addition salts of carbasugar amine derivatives
WO2007037423A1 (en) * 2005-09-29 2007-04-05 Kureha Corporation Antidiabetic agent
JP4966859B2 (en) * 2005-09-29 2012-07-04 智 熊沢 Antidiabetic
CN103688929A (en) * 2013-12-31 2014-04-02 福建省亚热带植物研究所 Validamycin nanocapsule, preparation method and application thereof

Similar Documents

Publication Publication Date Title
WO1995022974A3 (en) Film coated tablet of paracetamol and domperidone
JPS56104815A (en) Remedy for peripheral orthostatic hypotension
JPS5721320A (en) Blood sugar level depressing agent
JPS5759813A (en) Alpha-glucosidase inhibitor
AU574978B2 (en) Method for treatment of antidiuresis employing serine derivatives
JPS57140754A (en) Dihydroxybenzoic acid derivative and physiologically active preparation containing the same
JPS55122715A (en) Antidiabetic agent
JPS51128438A (en) An antibacterial drug against fish diseases
JPS5675428A (en) Hypoglycemic agent containing procainamide hydrochloride
JPS5759808A (en) Remedy and preventive for digestive ulcer
JPS57114512A (en) Antidia beticagent comprising (3-dimethyl-carbamoxy- phenyl)trimethyl ammonium derivative
JPS57128625A (en) Carcinostatic
WO1987003590A1 (en) Medicament for the treatment of diseases of the liver
JPS5742620A (en) Novel antiulcer agent
JPS57144216A (en) Antiulcer
JPS52111577A (en) Diaminomaleonitrile derivatives, their preparation and germicides and herbicides containing the same
JPS5668611A (en) Novel antiallergic agent
JPS54145206A (en) Blood sugar level depressing agent for oral administration
JPS5498339A (en) Carcinostatic agent
JPS54105237A (en) Analgesic agent containing nalorphine-6-glucuronide
JPS5352617A (en) Solid drug coating composition
JPS56138116A (en) Prophylactic and remedy for hepatolithiasis
JPS54145615A (en) Derivative of (1,3)-beta-d-glucane, its use and preparation
JPS57112327A (en) Antidiabetic agent comprising 2,3-dihydroxypropyl ester of n-(7-chloro-4-quinolyl)anthranillic acid
JPS57114518A (en) Hypotensive agent